Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma

International Journal of Surgical Pathology

Volumn 10, Issue 3, 2002, Pages 175-180

  Karbova, Eleonora ^a   Davidson, Ben ^a   Metodiev, Krassimir ^b   Tropé, Claes G ^a   Nesland, Jahn M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b VARNA UNIVERSITY OF MANAGEMENT   (Bulgaria)

Author keywords

Adenomatous polyposis coli protein; E cadherin; Immunohistochemistry; Serous ovarian carcinoma; catenin

Indexed keywords

APC PROTEIN; BETA CATENIN; UVOMORULIN; WNT PROTEIN;

ADULT; ARTICLE; COLON POLYPOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0036655796     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690201000302     Document Type: Article

References (31)

1. The hallmarks of cancer
2. The many faces of the tumor suppressor gene APC
3. A CINtillating new job for the APC tumor suppressor
4. The ABC of APC
5. APC gene: Database of germline and somatic mutations in human tumors and cell lines
6. The Cadherins: Cell-cell adhesion molecules controlling animal morphogenesis
7. Cadherin cell adhesion molecules with distinct binding specificities share a common structure
8. Cadherin cell adhesion receptors as a morphogenetic regulator
9. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules
10. Cadherins and catenins: Role in signal transduction and tumor progression
11. E-cadherin-mediated adhesion system in cancer cells
12. The oncogenic activation of β-catenin
13. Regulation of LEF-1/TCF transcription factors by Wnt and other signals
14. The role of beta-catenin in cell adhesion, signal transduction, and cancer
15. β-catenin signaling and cancer
16. Global cancer statistics
17. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
18. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumor suppressor gene locus at 5q13.1-21
19. Molecular genetic changes associated with ovarian cancer
20. No association of the I 1307K APC allele with ovarian cancer risk in Ashkenazi Jews
21. Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: More questions than answers
22. Rare activation of the TCF/β-catenin pathway in ovarian cancer
23. Mutations in the β-catenin gene (CTNNB1) in the endometrioid ovarian carcinomas
24. β-catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours
25. β-catenin expression pattern in stage I and II ovarian carcinomas. Relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome
26. Mutational analysis of β-catenin gene in Japanese ovarian carcinomas: Frequent mutations in endometrioid carcinomas
27. Surface epithelialstromal tumors
28. Sequence variants of the Axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK 3 binding
29. E-cadherin and α-, β- and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
30. E-cadherin complex protein expression and survival in ovarian carcinoma
31. Mutations of the E-cadherin gene in human gynecologic cancers